These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28249266)

  • 1. Role of the Intestinal Microbiome in Cholestatic Liver Disease.
    LaRusso NF; Tabibian JH; O'Hara SP
    Dig Dis; 2017; 35(3):166-168. PubMed ID: 28249266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice.
    Isaacs-Ten A; Echeandia M; Moreno-Gonzalez M; Brion A; Goldson A; Philo M; Patterson AM; Parker A; Galduroz M; Baker D; Rushbrook SM; Hildebrand F; Beraza N
    Hepatology; 2020 Dec; 72(6):2090-2108. PubMed ID: 32168395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enteric microbiome in hepatobiliary health and disease.
    Tabibian JH; Varghese C; LaRusso NF; O'Hara SP
    Liver Int; 2016 Apr; 36(4):480-7. PubMed ID: 26561779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.
    Fouts DE; Torralba M; Nelson KE; Brenner DA; Schnabl B
    J Hepatol; 2012 Jun; 56(6):1283-92. PubMed ID: 22326468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
    Jiang L; Schnabl B
    Physiology (Bethesda); 2020 Jul; 35(4):261-274. PubMed ID: 32490750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis and the intestinal microbiome; a focus on chronic liver disease.
    Beraza N
    Curr Opin Pharmacol; 2019 Dec; 49():76-81. PubMed ID: 31670055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intestinal microbiome and paediatric liver disease.
    Leung DH; Yimlamai D
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):446-455. PubMed ID: 28497760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How our understanding of the microbiome has changed the way we look at liver diseases.
    Adolph TE; Effenberger M; Tilg H
    Biomark Med; 2018 Nov; 12(11):1203-1206. PubMed ID: 30444134
    [No Abstract]   [Full Text] [Related]  

  • 11. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Gut Microbiota in Liver Disease.
    Brenner DA; Paik YH; Schnabl B
    J Clin Gastroenterol; 2015; 49 Suppl 1(0 1):S25-7. PubMed ID: 26447960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CHANGES IN MICROBIOCENOSIS OF THE COLON IN PATIENTS WITH CHRONIC LIVER DISEASE AND LATENT HEPATIC ENCEPHALOPATHY].
    Teterina LA; Curcumia DB; Seliverstov PV; Radchenko VG
    Eksp Klin Gastroenterol; 2015; (11):38-44. PubMed ID: 27214986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intestinal microbiome and health.
    Tuddenham S; Sears CL
    Curr Opin Infect Dis; 2015 Oct; 28(5):464-70. PubMed ID: 26237547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome alterations observed in liver diseases present opportunities for potential fecal transplantation.
    Heath RD; Mir F; Ibdah JA; Tahan V
    Turk J Gastroenterol; 2016 Nov; 27(6):495-498. PubMed ID: 27852539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microbiome and Primary Sclerosing Cholangitis.
    Ali AH; Carey EJ; Lindor KD
    Semin Liver Dis; 2016 Sep; 36(4):340-348. PubMed ID: 27997974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota and the liver.
    Shen TD; Pyrsopoulos N; Rustgi VK
    Liver Transpl; 2018 Apr; 24(4):539-550. PubMed ID: 29316191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the microbiota in the management of gastrointestinal and liver disease.
    Quigley EM; Monsour HP
    Rev Gastroenterol Peru; 2013; 33(2):139-44. PubMed ID: 23838941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.